WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII) today announced that it is offering to sell shares of its common stock and common stock purchase warrants in an underwritten public offering. All of the securities in the offering are to be sold by RXi. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
